Skip to main content Help with accessibility Skip to main navigation

ANDEXANET ALFA infusion (Ondexxya®▼) for reversing anticoagulation from apixaban or rivaroxaban

CCG Approval Status:

Date Added: 26 - May - 2021
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of ANDEXANET ALFA infusion (Ondexxya®▼), by specialists only, for reversing anticoagulation from apixaban or rivaroxaban in accordance with NICE TA697